BN Business News
Add your company to Business Communicator →

Business · 19/05/2004Updated: 10/17/2026 · 1 min read

FDA Extends Comment Period for Piroctone Olamine Review

Summary

The FDA is extending the comment period for its review of piroctone olamine, a potential ingredient for treating dandruff, until August 16, 2004, to allow more time for public input and data submission.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →